Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA? - Wikidata - wikimedia - TriplyDB

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

http://www.wikidata.org/entity/Q37780300

about

Juvenile Idiopathic Arthritis: Diagnosis and Treatment Population-based cohort study on the risk of malignancy in East Asian children with juvenile idiopathic arthritis Oral non-Hodgkin's lymphoma in a patient with rheumatoid arthritis treated with etanercept and methotrexate Rates of malignancy associated with juvenile idiopathic arthritis and its treatment TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications?The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis.Etanercept: efficacy and safety for approved indications.Update on biologicals for treatment of juvenile idiopathic arthritis.What is the background incidence of malignancy in children with rheumatic disease?Treatment in juvenile rheumatoid arthritis and new treatment options.Safety of biologic therapies for the treatment of juvenile idiopathic arthritis.Biological therapy and development of neoplastic disease in patients with juvenile rheumatic disease: a systematic review.Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors.Leukaemic transformation in patients with haematological disease receiving tumour necrosis factor inhibitors.

P2860

Q28079246-46F3CD5E-9A8B-4E53-B7B9-9D507FAAC751 Q34169257-91EC2B5A-2C46-489F-960F-7D87893D0453 Q35201455-6CD2466B-0E28-4D1A-A884-1691DDC55EFA Q35861269-17F377ED-8635-49A2-ADF3-B715E05491BB Q36361083-BB67122C-C09D-48E9-ABD4-B8ABD2CF0212 Q37803416-190766E1-F396-42E2-9C63-DD4EB950F522 Q37954714-110DA450-55B9-47CE-948A-4CF41A5CF438 Q38071693-3AFA8309-6DC4-4ECA-9AD0-C45B177DC8A0 Q38078882-A9AFC810-A9AE-4CAB-A4AF-BE57829238C7 Q38528889-BAB44C8A-800D-432F-A90F-3D34337B48A3 Q38530469-894CB812-68A6-4A38-9587-04F738A3C2AC Q39098069-15840410-F1A1-4369-948D-DDEFE9CCACC3 Q50027874-8904DEED-5591-43E2-9F3A-5291D5539E04 Q53131035-1968CBB5-F608-49C0-BA78-822F1834F3A6

P2860

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?

http://www.wikidata.org/entity/Q37780300

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Guilt by association - what is ...... eated with etanercept for JIA?

@en

Guilt by association - what is ...... eated with etanercept for JIA?

@nl

type

label

Guilt by association - what is ...... eated with etanercept for JIA?

@en

Guilt by association - what is ...... eated with etanercept for JIA?

@nl

prefLabel

Guilt by association - what is ...... eated with etanercept for JIA?

@en

Guilt by association - what is ...... eated with etanercept for JIA?

@nl

P1433

Q37780300-35B80E20-A5B3-4134-B724-6B64ED93A74E

P1476

Q37780300-3C2B6441-272D-48C5-8846-591E5730C931

P2093

Q37780300-E0C645D1-E44C-466A-89B9-0EB97525A20A

P2860

Q37780300-11A106CB-0ECD-4E67-9DCD-D81DC529E7FE

Q37780300-1397A09E-6CC7-4AB6-923C-EF04818FA64A

Q37780300-1F3F7502-A204-4986-8ACF-1CBA6558CEE6

Q37780300-28808FD5-8FCD-4BE9-8B5F-4826238F2AD2

Q37780300-3B4D7466-D338-4D03-916D-FBABE3AE38F0

Q37780300-6E58CBD8-1E6E-4B77-8BA3-736B4F585934

Q37780300-768E6536-2245-4232-AFEA-5FCDA90AFFAE

Q37780300-A4024E90-FBA7-4259-9D74-8A486624886C

Q37780300-A58AAFAB-9375-4AF7-89D0-0302C50540EC

Q37780300-A765687F-CE2C-4C89-A06C-815D9B6BFBA6

P2888

Q37780300-3C3D1241-BC3E-4357-B416-99A6E7AB4CA5

P304

Q37780300-15AECDBB-1661-4864-B927-3013435CCBFC

P31

Q37780300-232932CE-556C-4BA2-9CA8-614AAD4031DA

Q37780300-d7a87dc5-b160-4019-b423-e738f8bd3828

P356

Q37780300-88848AF2-A89D-40AE-AA41-5A6C8570AA89

P478

Q37780300-402041B5-487B-470E-BC8D-ADDA6DE97581

P50

Q37780300-71F5AD61-1740-422B-8827-80B5ED9B677A

P577

Q37780300-6FBCDE7C-A6A6-4837-B9AC-AB5594AA4178

P5875

Q37780300-38F87705-CD75-4AB0-B049-21E11B5B6789

P6179

Q37780300-5FB180F7-D459-4346-A32A-015A7CB5C4FA

P698

Q37780300-57CB8E3C-F4C4-4155-AB11-A5E7D5A81600

P932

Q37780300-C065D703-B821-470A-A29A-971E6BF87D54

P356

P1433

Pediatric Rheumatology Online Journal

P1476

Guilt by association - what is ...... eated with etanercept for JIA?

@en

P2093

Timothy Beukelman

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.

Summary of worldwide pediatric malignancies reported after exposure to etanercept.

Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma.

Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior?

Incidence of lymphoma in patients with rheumatoid arthritis: a systematic review of the literature.

Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?

Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review.

Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry.

P2888

P304

23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1546-0096-8-23

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Randy Quentin Cron

P577

2010-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45659197

http://www.w3.org/2001/XMLSchema#string

P6179

1003858820

http://www.w3.org/2001/XMLSchema#string

P698

20712883

http://www.w3.org/2001/XMLSchema#string

P932

2931479

http://www.w3.org/2001/XMLSchema#string